These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36836567)

  • 1. Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence.
    Méndez Hernández R; Ramasco Rueda F
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review.
    Backes Y; van der Sluijs KF; Mackie DP; Tacke F; Koch A; Tenhunen JJ; Schultz MJ
    Intensive Care Med; 2012 Sep; 38(9):1418-28. PubMed ID: 22706919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
    El-Mekkawy MS; Saleh NY; Sonbol AA
    Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
    Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
    J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary neutrophil gelatinase-associated lipocalin was a predictor from the day after intensive care unit entry, but not on the day of intensive care unit entry.
    Shimoyama Y; Kadono N; Umegaki O; Minami T
    Clin Chim Acta; 2021 Jun; 517():117-121. PubMed ID: 33667482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis.
    Hur M; Kim H; Lee S; Cristofano F; Magrini L; Marino R; Gori CS; Bongiovanni C; Zancla B; Cardelli P; Di Somma S
    BMC Infect Dis; 2014 Apr; 14():224. PubMed ID: 24761764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
    Sharma A; Ray S; Mamidipalli R; Kakar A; Chugh P; Jain R; Ghalaut MS; Choudhury S
    Indian J Crit Care Med; 2020 Apr; 24(4):245-251. PubMed ID: 32565634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia.
    van Oort PM; Bos LD; Póvoa P; Ramirez P; Torres A; Artigas A; Schultz MJ; Martin-Loeches I
    ERJ Open Res; 2019 Feb; 5(1):. PubMed ID: 30918897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome.
    Brodska H; Valenta J; Pelinkova K; Stach Z; Sachl R; Balik M; Zima T; Drabek T
    Clin Chem Lab Med; 2018 Mar; 56(4):658-668. PubMed ID: 29176018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.
    Brazzelli M; Aucott L; Aceves-Martins M; Robertson C; Jacobsen E; Imamura M; Poobalan A; Manson P; Scotland G; Kaye C; Sawhney S; Boyers D
    Health Technol Assess; 2022 Jan; 26(7):1-286. PubMed ID: 35115079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
    Kümpers P; Hafer C; Lukasz A; Lichtinghagen R; Brand K; Fliser D; Faulhaber-Walter R; Kielstein JT
    Crit Care; 2010; 14(1):R9. PubMed ID: 20122150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
    Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
    Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone.
    Keskinidou C; Vassiliou AG; Zacharis A; Jahaj E; Gallos P; Dimopoulou I; Orfanos SE; Kotanidou A
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. suPAR as a prognostic biomarker in sepsis.
    Donadello K; Scolletta S; Covajes C; Vincent JL
    BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.
    Gussen H; Hohlstein P; Bartneck M; Warzecha KT; Buendgens L; Luedde T; Trautwein C; Koch A; Tacke F
    J Intensive Care; 2019; 7():26. PubMed ID: 31061709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care.
    Llewelyn MJ; Berger M; Gregory M; Ramaiah R; Taylor AL; Curdt I; Lajaunias F; Graf R; Blincko SJ; Drage S; Cohen J
    Crit Care; 2013 Mar; 17(2):R60. PubMed ID: 23531337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
    Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
    Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
    Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
    Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.